483 Sarepta Therapeutics Apr 2018

483 Sarepta Therapeutics Apr 2018

Kent Conforti FDA$119.00 - Available Now

FDA investigators audited the Sarepta Therapeutics - Cambridge, MA, United States facility and issued inspectional observations (via FDA 483) on 12 Apr 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 12 Apr 2018
  • Location: Cambridge, United States
  • FEI: 3011431238
Add To Cart